Provided by Tiger Trade Technology Pte. Ltd.

Contineum Therapeutics, INC.

14.06
-0.3100-2.16%
Post-market: 14.060.00000.00%19:34 EDT
Volume:122.84K
Turnover:1.73M
Market Cap:524.94M
PE:-7.35
High:14.45
Open:14.45
Low:13.78
Close:14.37
52wk High:16.91
52wk Low:5.07
Shares:37.34M
Float Shares:27.59M
Volume Ratio:0.67
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9138
EPS(LYR):-2.1700
ROE:-26.88%
ROA:-18.18%
PB:2.10
PE(LYR):-6.48

Loading ...

Company Profile

Company Name:
Contineum Therapeutics, INC.
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
51
Office Location:
3565 General Atomics Court,Suite 200,San Diego,California,United States
Zip Code:
92121
Fax:
- -
Introduction:
- -

Directors

Name
Position
Carmine Stengone
Chief Executive Officer, President and Director
Evert Schimmelpennink
Chair of the Board
Clare R. Ozawa
Director
Lori M. Lyons Williams
Director
Olivia Ware
Director
Stefan M. Larson
Director
Todd R. Brady
Director

Shareholders

Name
Position
Carmine Stengone
Chief Executive Officer, President and Director
Peter T. Slover
Chief Financial Officer
Stephen L. Huhn
Chief Medical Officer and Senior Vice President, Clinical Development
Daniel S. Lorrain
Chief Science Officer